Dynatrace Prices IPO

7/31/19

WALTHAM, Mass.--(BUSINESS WIRE)--Software intelligence company, Dynatrace, Inc. (NYSE: DT), today announced the pricing of its initial public offering of 35,609,612 shares of common stock at a public offering price of $16.00 per share. The offering consists of 34,000,000 shares offered by Dynatrace and 1,609,612 shares to be sold by certain of Dynatrace’s existing stockholders. In addition, Dynatrace and certain of the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 4,873,174 shares from Dynatrace and 468,267 shares from certain of the selling stockholders at the public offering price, less underwriting discounts and commissions. The gross proceeds to Dynatrace from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Dynatrace, are expected to be $544.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol “DT” on August 1, 2019. The offering is expected to close on August 5, 2019, subject to customary closing conditions.

Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Citigroup Global Markets Inc. are acting as lead book-running managers for the offering. Barclays Capital Inc., Jefferies LLC, RBC Capital Markets, LLC and UBS Securities LLC are also acting as book-running managers. KeyBanc Capital Markets Inc., William Blair & Company, L.L.C., Canaccord Genuity LLC, JMP Securities LLC and Macquarie Capital (USA) Inc. are acting as co-managers.

About Dynatrace 

Dynatrace provides software intelligence to simplify enterprise cloud complexity and accelerate digital transformation. With AI and complete automation, Dynatrace’s all-in-one platform provides answers, not just data, about the performance of applications, the underlying infrastructure and the experience of all users.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.